Raily Aesthetic Medicine International Holdings Limited released an update on 27 March 2026 outlining the composition of its Board of Directors and the distribution of responsibilities across four specialised committees.

The Board now comprises six members: three Executive Directors—Mr. Fu Haishu (Chairman), Mr. Song Jianliang (Chief Executive Officer) and Mr. Wang Ying—and three Independent Non-executive Directors—Dr. Lin Hai, Ms. Yang Xiaofen and Mr. Liu Teng.

Committee assignments are as follows:

• Audit Committee: chaired by Mr. Liu Teng with Dr. Lin Hai and Ms. Yang Xiaofen as members.

• Remuneration Committee: chaired by Dr. Lin Hai; Ms. Yang Xiaofen serves as a member.

• Nomination Committee: chaired by Dr. Lin Hai, joined by Mr. Fu Haishu and Ms. Yang Xiaofen.

• Strategic Investment Committee: chaired by Mr. Fu Haishu with Dr. Lin Hai as a member.

The disclosure provides investors with an updated governance structure, reflecting the company’s commitment to defined oversight across audit, remuneration, nomination and strategic investment functions.